Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus

Dicky L. Tahapary, Atikah I. Fatya, Farid Kurniawan, Cicilia Marcella, Ikhwan Rinaldi, Tri J.E. Tarigan, Dante S. Harbuwono, Em Yunir, Pradana Soewondo, Dyah Purnamasari

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Background Obesity is a traditional risk factor for type 2 diabetes mellitus (T2DM). However, recent studies reported that metabolically unhealthy obesity (MUO) exerts a higher risk of developing T2DM than metabolically healthy obesity (MHO) because of its higher state of insulin resistance. This may happen due to metabolic endotoxemia through gut dysbiosis and increased intestinal permeability. Our study aimed to know the association of intestinal permeability using intestinal fatty acid-binding protein (I-FABP) with obesity-related T2DM patients in Indonesia. Methods This was a cross-sectional study that recruited 63 participants with obesity defined using body mass index (BMI) classification for the Asia-Pacific population (BMI ≥25 kg/m2). All participants were then grouped into T2DM and non-T2DM based on American Diabetes Association (ADA) diagnostic criteria. The I-FABP levels were measured using the enzyme-linked immunosorbent assay method. Results The I-FABP level of T2DM group was higher compared to non-T2DM group, namely 2.82 (1.23) ng/mL vs. 1.78 (0.81) ng/mL (p<0.001; mean difference 1.033 with 95% CI 0.51-1.55). This difference was not attenuated even after adjustment for age. The fitted regression model using linear regression was: i-FABP = 1.787+1.034*(DM) (R2 = 18.20%, standardized ß = 0.442, p<0.001). Conclusions This study underscores the association of intestinal permeability with T2DM in people with obesity and supports the evidence of the potential role of intestinal permeability in the pathogenesis of obesity-related T2DM.

Original languageEnglish
Article numbere0279915
JournalPloS one
Issue number1 January
Publication statusPublished - Jan 2023


Dive into the research topics of 'Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this